第二起全国性结核病暴发由含活细胞骨同种异体移植物引起——美国,2023年
2023年7月,CDC接到两州各一例脊柱术后结核病报告,均使用同一 deceased donor 的含活细胞骨同种异体移植物。CDC与FDA调查确定该产品来自与2021年暴发不同的供者,已分发至七州13家医疗机构。截至2023年12月20日,36名手术受者中5例实验室确诊结核病,2例死于结核病;未使用产品的结核分枝杆菌培养阳性,全基因组测序显示与受者培养株遗传相关。公共卫生应对避免了最多53例额外手术,但亟需额外措施保护患者免受组织传播结核分枝杆菌。
要点
- 含活细胞骨同种异体移植物可传播结核分枝杆菌,即使核酸检测阴性。
- 36名手术受者中5例实验室确诊结核病,2例死亡。
- 公共卫生应对阻止了最多53例使用该供者移植物的额外手术。
核心结论
- 第二起全国性结核病暴发由同一组织库生产的含活细胞骨同种异体移植物引起,供者与2021年暴发不同。
- 公共卫生应对阻止了最多53例使用该供者移植物的额外手术。
- 亟需额外措施保护患者免受组织传播的结核分枝杆菌感染。
研究设计与样本
- CDC与FDA联合调查,2023年7月7日至11日收到两州各一例脊柱术后结核病报告。
- 产品分发至七州13家医疗机构,2023年7月12日通知所有七州。
- 截至2023年12月20日,36名手术骨同种异体移植物受者中5例实验室确诊结核病。
主要发现
- 36名手术受者中5例实验室确诊结核病,2例死于结核病。
- 全基因组测序显示手术受者阳性结核分枝杆菌培养与未使用产品培养株遗传相关。
- 未使用产品在分发前核酸检测阴性,但结核分枝杆菌培养在暴发识别后才进行。
临床怎么用
- 公共卫生应对阻止了最多53例使用该供者移植物的额外手术。
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During July 7-11, 2023, CDC received reports of two patients in different states with a tuberculosis (TB) diagnosis following spinal surgical procedures that used bone allografts containing live cells from the same deceased donor. An outbreak associated with a similar product manufactured by the same tissue establishment (i.e., manufacturer) occurred in 2021. Because of concern that these cases represented a second outbreak, CDC and the Food and Drug Administration worked with the tissue establishment to determine that this product was obtained from a donor different from the one implicated in the 2021 outbreak and learned that the bone allograft product was distributed to 13 health care facilities in seven states. Notifications to all seven states occurred on July 12. As of December 20, 2023, five of 36 surgical bone allograft recipients received laboratory-confirmed TB disease diagnoses; two patients died of TB. Whole-genome sequencing demonstrated close genetic relatedness between positive Mycobacterium tuberculosis cultures from surgical recipients and unused product. Although the bone product had tested negative by nucleic acid amplification testing before distribution, M. tuberculosis culture of unused product was not performed until after the outbreak was recognized. The public health response prevented up to 53 additional surgical procedures using allografts from that donor; additional measures to protect patients from tissue-transmitted M. tuberculosis are urgently needed.
引用
- Wortham JM, Haddad MB, Stewart RJ, et al. Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells - United States, 2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38175804. doi:10.15585/mmwr.mm725253a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。